Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1276

1.

Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.

McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.

J Clin Virol. 2006 Jul;36(3):166-76. Epub 2006 Jan 20.

PMID:
16427802
2.

Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.

Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A.

Vox Sang. 2007 Jan;92(1):8-14.

PMID:
17181585
3.

Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.

Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT.

Transfusion. 2005 Aug;45(8):1258-66. Erratum in: Transfusion. 2005 Dec;45(12):1988.

PMID:
16078910
4.

Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.

Xiao X, Zhai J, Zeng J, Tian C, Wu H, Yu Y.

J Virol Methods. 2013 Feb;187(2):357-61. doi: 10.1016/j.jviromet.2012.10.015. Epub 2012 Nov 8.

PMID:
23142222
5.

Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.

Nübling CM, Chudy M, Volkers P, Löwer J.

Transfusion. 2006 Nov;46(11):1886-91.

PMID:
17076842
6.

Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.

Meng Q, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sakakura Y, Hirose T, Impraim C.

J Clin Microbiol. 2001 Aug;39(8):2937-45.

7.
8.

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.

Transfusion. 2007 Oct;47(10):1803-8.

PMID:
17880604
9.

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.

Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K; Japanese Red Cross NAT Research Group.

J Virol Methods. 2003 Sep;112(1-2):145-51.

PMID:
12951223
10.

Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.

Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P.

Transfusion. 2009 Feb;49(2):301-10. doi: 10.1111/j.1537-2995.2008.01966.x.

PMID:
19389212
11.

The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.

Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S, Tomono T, Murozuka T, Takeda Y, Doi Y, Mine H, Yokoyama S, Hirose T, Nishioka K; Japanese Red Cross NAT Screening Research Group.

Microbiol Immunol. 2001;45(9):667-72.

12.

Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.

Nübling CM, Unkelbach U, Chudy M, Seitz R.

Transfusion. 2008 May;48(5):822-6. doi: 10.1111/j.1537-2995.2007.01612.x. Epub 2008 Jan 15.

PMID:
18208414
13.

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.

Vargo J, Smith K, Knott C, Wang S, Fang C, McDonough S, Giachetti C, Caglioti S, Gammon R, Gilbert D, Jackson JB, Richards W, Stramer S, Mimms L.

Transfusion. 2002 Jul;42(7):876-85.

PMID:
12375660
14.

The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.

Yang MH, Li L, Hung YS, Hung CS, Allain JP, Lin KS, Tsai SJ.

Transfusion. 2010 Jan;50(1):65-74. doi: 10.1111/j.1537-2995.2009.02357.x. Epub 2009 Aug 26.

PMID:
19709394
15.

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.

Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C; Working Group for NAT Study in Thai Blood Donations.

Transfusion. 2009 Jun;49(6):1126-35. doi: 10.1111/j.1537-2995.2009.02176.x. Epub 2009 Apr 21.

PMID:
19392770
16.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
17.

Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.

Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P.

Transfusion. 2009 Feb;49(2):289-300. doi: 10.1111/j.1537-2995.2008.01965.x. Epub 2008 Nov 4.

PMID:
19000230
18.

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.

Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.

Transfusion. 2008 Jun;48(6):1198-206. doi: 10.1111/j.1537-2995.2008.01672.x. Epub 2008 Apr 14.

PMID:
18422856
19.

HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.

Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M.

J Clin Virol. 2007 Aug;39(4):282-7. Epub 2007 Jul 5.

PMID:
17611148
20.

Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.

Candotti D, Temple J, Owusu-Ofori S, Allain JP.

J Virol Methods. 2004 Jun 1;118(1):39-47.

PMID:
15158067

Supplemental Content

Support Center